SLIDE 8 5/17/13 8
PHM Choosing Wisely
Adapted from Monash & Le, UCSF Grand Rounds 2013
!"#$%&"'()'&*+),%&'-(."/'-0+,&.#&*+.1(')#&2.%+&3#*"401.*-%)(&-,%+4-&& "'&5'"#*+."1.%.,6
!"#$%&"'()*$+,'$&,-(".#$/*'"#,("(.,'$"&/,(%&(012-$/"'(,3"4$&"#$%&("&+(0"#$,&#(1$-#%.2(5%.(+$")&%-$-(%5("-#14"("&+(6.%&/1$%'$#$-($&(#1,(0,+$"#.$/( 0%0*'"#$%&7(8*'#$0',(-#*+$,-(1"9,(,-#"6'$-1,+('$4$#,+(/'$&$/"'(*#$'$#2(%5(/1,-#(."+$%)."01-(5%.(0"#$,&#-(:$#1("-#14"(%.(6.%&/1$%'$#$-7(;4$--$%&(%5(#1,(( *-,(%5(/1,-#(."+$%)."012(:$''(.,+*/,(/%-#-<(6*#(&%#(/%40.%4$-,(+$")&%-#$/("//*."/2("&+(/".,7
!"#$%&'"3%.#)17&3,)&5'"#*+"(.1-%"',&.#&*+.1(')#&2.%+&5'"#*+."1.%.,6
=*6'$-1,+()*$+,'$&,-(+%(&%#("+9%/"#,(#1,(.%*#$&,(*-,(%5(6.%&/1%+$'"#%.-($&(0"#$,&#-(:$#1(6.%&/1$%'$#$-7(>%40.,1,&-$9,(.,9$,:-(%5(#1,('$#,."#*.,(1"9,(
- $-('$4$#,+(+,4%&-#."#$%&(%5(/',".($40"/#(%5(6.%&/1%+$'"#%.(#1,."02(*0%&(#1,(/%*.-,(%5(+$-,"-,7(?++$#$%&"''2<(0.%9$+,.-(-1%*'+(/%&-$+,.(#1,(0%#,&#$"'(
$40"/#(%5("+9,.-,(,9,&#-(*0%&(#1,(0"#$,
!"#$%&3,)&,7,%)4.*&*"'%.*",%)'".(,&.#&*+.1(')#&3#()'&8&7)-',&"9&-/)&& 2.%+&-#&3#*"401.*-%)(&1"2)'&'),0.'-%"'7&%'-*%&.#9)*%."#6
=*6'$-1,+()*$+,'$&,-(.,/%44,&+(#1"#(/%.#$/%-#,.%$+(4,+$/"#$%&-(&%#(6,(*-,+(.%*#$&,'2($&(#1,(4"&"),4,&#(%5(6.%&/1$%'$#$-7(@*.#1,.4%.,<("++$#$%&"'(
- ,300'),,."#&%+)'-076
- (
- :$#1("/$+(-*00.,--$%&(#1,."027
- (
( %.(:,''(+%/*4,&#,+7
3 1 2 5 4
- !"#$%&'(")(*"+,$&-.(/%0$#$1%(2(:)(.-%'.*&;",0.%-1&<)(.*.#)
=.>)&?+.#/,&:+7,.*.-#,&&
- #(&:-%.)#%,&@+"31(&A3),%."#
http://www.choosingwisely.org
QI Approach
Consensus Measure current Define a shared goal (achievable) Intervention Re-measure Modify intervention
10 20 30 40 50 60 70 80
Bronchodilators CXR Steroids Chest PT Mean use (2009) Target
VIP Inpatient Data